Cargando…

How to develop therapeutic and translational research collaborations with industry

Discovery and development of new medicines requires the talent and passion of both academic and industrial scientists. Identifying the optimal set of circumstances for direct collaboration between academic and industry teams requires a mutual understanding of what each partner brings to the relation...

Descripción completa

Detalles Bibliográficos
Autores principales: Kleiman, Robin J., Ehlers, Michael D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society for Cell Biology 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789159/
https://www.ncbi.nlm.nih.gov/pubmed/31609671
http://dx.doi.org/10.1091/mbc.E19-05-0261
_version_ 1783458591728992256
author Kleiman, Robin J.
Ehlers, Michael D.
author_facet Kleiman, Robin J.
Ehlers, Michael D.
author_sort Kleiman, Robin J.
collection PubMed
description Discovery and development of new medicines requires the talent and passion of both academic and industrial scientists. Identifying the optimal set of circumstances for direct collaboration between academic and industry teams requires a mutual understanding of what each partner brings to the relationship, and an appreciation of the specialized capabilities and scope of work to be undertaken by each group. We provide our perspective on the who, what, where, why, and how for establishing therapeutic and translational research collaborations between academic and industry scientists.
format Online
Article
Text
id pubmed-6789159
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher The American Society for Cell Biology
record_format MEDLINE/PubMed
spelling pubmed-67891592019-12-30 How to develop therapeutic and translational research collaborations with industry Kleiman, Robin J. Ehlers, Michael D. Mol Biol Cell Perspectives Discovery and development of new medicines requires the talent and passion of both academic and industrial scientists. Identifying the optimal set of circumstances for direct collaboration between academic and industry teams requires a mutual understanding of what each partner brings to the relationship, and an appreciation of the specialized capabilities and scope of work to be undertaken by each group. We provide our perspective on the who, what, where, why, and how for establishing therapeutic and translational research collaborations between academic and industry scientists. The American Society for Cell Biology 2019-10-15 /pmc/articles/PMC6789159/ /pubmed/31609671 http://dx.doi.org/10.1091/mbc.E19-05-0261 Text en © 2019 Kleiman and Ehlers. “ASCB®,” “The American Society for Cell Biology®,” and “Molecular Biology of the Cell®” are registered trademarks of The American Society for Cell Biology. http://creativecommons.org/licenses/by-nc-sa/3.0 This article is distributed by The American Society for Cell Biology under license from the author(s). Two months after publication it is available to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Creative Commons License.
spellingShingle Perspectives
Kleiman, Robin J.
Ehlers, Michael D.
How to develop therapeutic and translational research collaborations with industry
title How to develop therapeutic and translational research collaborations with industry
title_full How to develop therapeutic and translational research collaborations with industry
title_fullStr How to develop therapeutic and translational research collaborations with industry
title_full_unstemmed How to develop therapeutic and translational research collaborations with industry
title_short How to develop therapeutic and translational research collaborations with industry
title_sort how to develop therapeutic and translational research collaborations with industry
topic Perspectives
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789159/
https://www.ncbi.nlm.nih.gov/pubmed/31609671
http://dx.doi.org/10.1091/mbc.E19-05-0261
work_keys_str_mv AT kleimanrobinj howtodeveloptherapeuticandtranslationalresearchcollaborationswithindustry
AT ehlersmichaeld howtodeveloptherapeuticandtranslationalresearchcollaborationswithindustry